HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnosis and treatment of latent tuberculosis in patients with chronic inflammatory diseases: use of TNF-alpha-targeting biological products.

AbstractOBJECTIVE:
To determine the clinical and epidemiological profile of patients who are candidates for TNF-α inhibitor use and are classified as having latent tuberculosis (LTB), as well as to evaluate the outcomes of prophylactic treatment with isoniazid.
METHODS:
A prospective descriptive analysis followed by an analytical, observational, cross-sectional study of the outcomes of prophylactic treatment in a group of 45 candidates for TNF-α inhibitor use. We evaluated the patients through anamnesis, clinical examination, chest X-ray, and tuberculin skin test (TST) using the Mantoux method.
RESULTS:
The mean age was 45 years, and 56.0% of the patients were female. Chronic rheumatic diseases, chronic dermatological diseases, and Crohn's disease were present in 46.7%, 40.0%, and 13.3% of the patients, respectively. The mean TST induration was 14.6 mm (range: 5-30 mm). The majority (n = 30) of the 45 patients (66.7%) had an induration > 10 mm. In the 16 patients with BCG vaccination scars, the mean induration was 15.7 mm, and 14 of those patients had an induration > 10 mm. Chest X-ray results were considered normal, with minimal alterations, in 64.4% and 35.6% of the patients, respectively. The treatment with isoniazid was abandoned by 1 patient (2.2%) and completed by 41 (91.2%), whereas it was interrupted because of drug-induced hepatitis in 2 (4.4%), and 1 patient (2.2%) was transferred to another hospital. Of those who completed the treatment, 5 experienced mild side effects.
CONCLUSIONS:
Determining the profile of candidates for TNF-α inhibitor use is important for the management of LTB treatment and for the establishment of clinical protocols for the use and monitoring of the use of these medications.
AuthorsDiana Maria de Almeida Lopes, Valéria Goes Ferreira Pinheiro, Helena Serra Azul Monteiro, José Ajax Nogueira Queiroz, Lucivaldo Dos Santos Madeira, Mônica Maria de Almeida Lopes
JournalJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia (J Bras Pneumol) 2011 May-Jun Vol. 37 Issue 3 Pg. 308-16 ISSN: 1806-3756 [Electronic] Brazil
PMID21755185 (Publication Type: Journal Article)
Chemical References
  • Antitubercular Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Isoniazid
Topics
  • Adolescent
  • Adult
  • Antitubercular Agents (therapeutic use)
  • Child
  • Chronic Disease
  • Epidemiologic Methods
  • Female
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Inflammation (drug therapy, microbiology)
  • Isoniazid (therapeutic use)
  • Latent Tuberculosis (diagnosis, drug therapy)
  • Male
  • Middle Aged
  • Tuberculin Test
  • Tuberculosis, Pulmonary (prevention & control)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: